CORINDUS VASCULAR ROBOTICS, INC
CVRS
CVRS was delisted on the 28th of October, 2019.
58 hedge funds and large institutions have $99M invested in CORINDUS VASCULAR ROBOTICS, INC in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 5 closing their positions.
160% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 10
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
7% more funds holding
Funds holding: 54 → 58 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less capital invested
Capital invested by funds: $123M → $99M (-$23.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.34M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.07M |
| 3 |
BlackRock
New York
|
+$764K |
| 4 |
Charles Schwab
San Francisco,
California
|
+$164K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$132K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$5.45M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$168K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$59.1K |
| 4 |
Millennium Management
New York
|
-$37K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$33K |
CVRS Hedge Fund Activity: Q3 2017 in Review
58 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q3 2017, worth a combined $99M — down 19% from $123M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CVRS positions and 5 closed out — a net gain of 4 holders — while 26 added to existing stakes and 10 trimmed.
The largest buyer was Essex Investment Management, opening a new position worth an estimated $1.34M. The largest seller was Consonance Capital Management, cutting an estimated $5.45M.
- 58 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q3 2017, up from 54 in Q2 2017.
- Funds reported $99M of CORINDUS VASCULAR ROBOTICS, INC stock for Q3 2017, down 19% quarter-over-quarter.
- 9 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q3 2017 and 5 closed out, a net change of +4 holders.
- The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q3 2017 was Essex Investment Management, an estimated $1.34M added.
- The largest CORINDUS VASCULAR ROBOTICS, INC seller in Q3 2017 was Consonance Capital Management, an estimated $5.45M sold.
Based on aggregated 13F filings for Q3 2017.